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Abstract 
A series of chlorinated 3,5-diaryl-2-pyrazolines has been synthesized by the reaction of 
appropriately substituted chlorochalcones and mono-substituted hydrazines in hot acetic acid 
solution. The structures of all new compounds have been elucidated by microanalysis and 1H- 
and 13C- NMR spectroscopic measurements. 
 






Pyrazolines are well known, and important nitrogen-containing five-membered heterocyclic 
compounds and various methods have been worked out for their synthesis.1–4 Several pyrazoline 
derivatives have been found to possess considerable biological activities, which stimulated 
research activity in this field. Their prominent effects are e.g., antimicrobial,5 central nervous 
system,6 and immunosuppressive7 activities. 2-Pyrazolines seem to be the most frequently 
studied pyrazoline type compounds. After the pioneering work of Fischer and Knövenagel in the 
late nineteenth century,8 the reaction of α,β-unsaturated aldehydes and ketones with hydrazines 
became one of the most popular methods for the preparation of 2-pyrazolines.9–36 As a result, 
numerous substituted 2-pyrazolines have been synthesized, which has made possible structure–
activity relationship investigations of these substances. As a continuation of our previous studies 
in this field,23–25,29,30,34–36 we report here the synthesis of new 1-substituted 3,5-diaryl-2-
pyrazolines which are chlorinated in their aromatic rings. 
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Results and Discussion 
 
Numerous chlorinated organic compounds have various bioactivities which render them valuable 
active ingredients of medicines or plant protecting agents. As mentioned, pyrazolines possess 
important pharmacological activities,5–7 and therefore they are useful materials in drug research. 
Taking into consideration the possible beneficial effects of the presence of chlorine atom(s) in an 
organic compound, it appeared expedient to synthesize a series of systematically chlorinated 2-
pyrazolines to afford substances for a structure–activity relationship study. Although several 
chlorinated 2-pyrazolines have already been prepared,15,17,21,27,28,33 these compounds were 
individual members of variously substituted 2-pyrazoline series. For this reason, our aim was to 
synthesize 1-substituted 3,5-diaryl-2-pyrazolines, chlorinated in their aromatic rings connected 
to the C-3 and C-5 atoms of the pyrazoline skeleton, by the reaction of chlorochalcones with 
hydrazines. 
The chlorochalcones 1–16 were allowed to react with hydrazine hydrate or phenylhydrazine 
in hot acetic acid to afford 1-acetyl-3,5-diaryl-2-pyrazolines 17–28 or 3,5-diaryl-1-phenyl-2-
pyrazolines 29–43 in good yields (65–93%) (Scheme 1). Utilization of chalcones substituted at 
the para- position of ring A made possible the synthesis of 3,5-diaryl-2-pyrazolines appropriately 
substituted at the para- position of their 3-aryl group. The ring B of the starting chalcones 1–16 
was mono- or dichlorinated at specific positions. Use of these starting materials made available 
the preparation of a series of systematically substituted 3,5-diaryl-2-pyrazolines. These new 
compounds, together with the related known substances, provide useful materials for structure–
activity relationship studies. 
The structures of all new 2-pyrazolines 17–43 have been elucidated by elemental analyses, 
1H- and 13C-NMR spectroscopic measurements. In the 1H-NMR spectra of compounds 17–43, 
the three protons attached to the C-4 and C-5 carbon atoms of the 2-pyrazoline ring gave an 
ABX spin system. Chemical shifts and the coupling constant values (cf. Experimental Section) 
unequivocally prove a 2-pyrazoline structure. In the 1-acetyl derivatives 17–28 a singlet signal at 
about δ 2.4 reveals the presence of the N-acetyl group. Singlet signals of the methyl or methoxy 
substituents have also been assigned in each case. 13C-NMR chemical shift values of the carbon 
atoms at 40–45 (C-4), 55–62 (C-5) and about 153 or 146 ppm (C-3) corroborate the 2-pyrazoline 
character deduced from the 1H- NMR data. The presence of an N-acetyl group is also confirmed 
by the 13C- chemical shifts of these two carbon atoms detected at about 21 (CH3) and 168 (C=O) 
ppm. 
In conclusion, we have synthesized a systematically substituted series of new, chlorinated 
3,5-diaryl-2-pyrazolines for structure–activity relationship studies. The 1-substituted 2- 
pyrazolines are very stable compounds, which renders them beneficial substances for biological 
or pharmacological trials.  
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X = H, Ph 12
3 4 5
1-16 17-43
 1, 17: R1 = H, R2 = 3-Cl, R3 = Ac
2, 18: R1 = H, R2 = 4-Cl, R3 = Ac
3, 19: R1 = H, R2 = 2,4-Cl2, R3 = Ac
4, 20: R1 = H, R2 = 3,4-Cl2, R3 = Ac
5, 21: R1 = 4-Me, R2 = 3-Cl, R3 = Ac
6, 22: R1 = 4-Me, R2 = 4-Cl, R3 = Ac
7, 23: R1 = 4-Me, R2 = 2,4-Cl2, R3 = Ac
8, 24: R1 = 4-Me, R2 = 2,6-Cl2, R3 = Ac
9, 25: R1 = 4-MeO, R2 = 2,4-Cl2, R3 = Ac
10, 26: R1 = 4-MeO, R2 = 2,6-Cl2, R3 = Ac
3, 31: R1 = H, R2 = 2,4-Cl2, R3 = Ph
14, 32: R1 = H, R2 = 2,6-Cl2, R3 = Ph
4, 33: R1 = H, R2 = 3,4-Cl2, R3 = Ph
5, 34: R1 = 4-Me, R2 = 3-Cl, R3 = Ph
6, 35: R1 = 4-Me, R2 = 4-Cl, R3 = Ph
7, 36: R1 = 4-Me, R2 = 2,4-Cl2, R3 = Ph
8, 37: R1 = 4-Me, R2 = 2,6-Cl2, R3 = Ph
9, 38: R1 = 4-MeO, R2 = 2,4-Cl2, R3 = Ph
10, 39: R1 = 4-MeO, R2 = 2,6-Cl2, R3 = Ph  
11, 27: R1 = 4-Cl, R2 = 2,4-Cl2, R3 = Ac
12, 28: R1 = 4-Cl, R2 = 2,6-Cl2, R3 = Ac
13, 29: R1 = H, R2 = 2-Cl, R3 = Ph
2, 30: R1 = H, R2 = 4-Cl, R3 = Ph
15, 40: R1 = 4-F, R2 = 3,4-Cl2, R3 = Ph
11, 41: R1 = 4-Cl, R2 = 2,4-Cl2, R3 = Ph
12, 42: R1 = 4-Cl, R2 = 2,6-Cl2, R3 = Ph







General Procedures. Melting points were determined with a Kofler hot-stage apparatus and are 
uncorrected. 1H- and 13C- NMR spectra were recorded on a Varian Gemini 200 spectrometer at 
200/50 MHz in CDCl3 (internal standard TMS, δ = 0.0 ppm) at ambient temperature (ca 20 oC). 
Elemental analyses were measured in-house with a Carlo Erba 1106 EA instrument. TLC was 
performed on Kieselgel 60 F254 (Merck) layer using toluene:ethyl acetate (4:1 v/v) or 
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General procedure for the preparation of compounds 17–43 
A mixture of chlorochalcone (1–16, 10.0 mmoles), hydrazine hydrate (50.0 mmoles) or phenyl 
hydrazine (50.0 mmoles) and acetic acid (60 mL) was heated at reflux for 3 h, then poured onto 
crushed ice. The precipitate was separated by filtration, washed with water, and crystallized from 
methanol to obtain the 2-pyrazolines 17–43 (Scheme 1). 
1-Acetyl-5-(3-chlorophenyl)-3-phenyl-2-pyrazoline (17). Obtained as white needles in 90% 
yield, mp 120–121 oC; 1H NMR (δ): 2.45 (3H, s, Me), 3.10 (1H, dd, J = 5.2, 17.8 Hz, 4-Htrans), 
3.77 (1H, dd, J = 11.4, 17.8 Hz, 4-Hcis), 5.53 (1H, dd, J = 5.2, 11.4 Hz, 5-H), 7.10–7.76 (m, 9x 
arom. H); 13C-NMR (δ): 21.9, 42.2, 59.4, 123.8, 125.7, 126.6, 127.8, 128.7, 130.2, 130.4, 131.1, 
134.7, 143.8, 153.6, 168.8; Anal. Calcd. for C17H15ClN2O: C, 68.34; H, 5.06; N, 9.37. Found: C, 
68.46; H, 5.11; N, 9.28%. 
1-Acetyl-5-(4-chlorophenyl)-3-phenyl-2-pyrazoline (18). Isolated as white needles in 67% 
yield, mp 108–109 oC; 1H NMR (δ): 2.41 (3H, s, Me), 3.13 (1H, dd, J = 5.0, 18.1 Hz, 4-Htrans), 
3.76 (1H, dd, J = 10.8, 18.1 Hz, 4-Hcis), 5.66 (1H, dd, J = 5.0, 10.8 Hz, 5-H), 7.14–7.75 (m, 9x 
arom. H); 13C- NMR (δ): 21.9, 42.2, 59.3, 126.5, 127.1, 128.7, 129.0, 130.4, 131.2, 133.4, 140.3, 
153.6, 168.8; Anal. Calcd. for C17H15ClN2O: C, 68.34; H, 5.06; N, 9.37. Found: C, 68.24; H, 
5.02; N, 9.48%. 
1-Acetyl-5-(2,4-dichlorophenyl)-3-phenyl-2-pyrazoline (19). Obtained as white plates, in 74% 
yield, mp 137–138 oC; 1H- NMR (δ): 2.47 (3H, s, Me), 3.04 (1H, dd, J = 4.9, 17.6 Hz, 4-Htrans), 
3.83 (1H, dd, J = 10.8, 17.6 Hz, 4-Hcis), 5.84 (1H, dd, J = 4.9, 10.8 Hz, 5-H), 6.98–7.75 (m, 8x 
arom. H); 13C- NMR (δ): 21.8, 41.2, 57.3, 126.5, 126.9, 127.5, 128.7, 129.7, 130.4, 131.0, 132.4, 
133.8, 137.2, 154.0, 168.8; Anal. Calcd. for C17H14Cl2N2O: C, 61.27; H, 4.23; N, 8.40. Found: C, 
61.40; H, 4.28; N, 8.49%. 
1-Acetyl-5-(3,4-dichlorophenyl)-3-phenyl-2-pyrazoline (20). Prepared as white plates in 70% 
yield, mp 134–135 oC; 1H- NMR (δ): 2.42 (3H, s, Me), 3.12 (1H, dd, J = 4.9, 17.8 Hz, 4-Htrans), 
3.76 (1H, dd, J = 11.8, 17.8 Hz, 4-Hcis), 5.52 (1H, dd, J = 4.9, 11.8 Hz, 5-H), 7.06–7.75 (m, 8x 
arom. H); 13C- NMR (δ): 21.8, 42.1, 59.0, 125.2, 126.6, 127.7, 128.8, 130.5, 130.9, 131.7, 133.0, 
142.0, 153.6, 168.9; Anal. Calcd. for C17H14Cl2N2O: C, 61.27; H, 4.23; N, 8.40. Found: C, 
61.16; H, 4.18; N, 8.46%. 
1-Acetyl-5-(3-chlorophenyl)-3-(4-methylphenyl)-2-pyrazoline (21). Obtained as white needles 
in 78% yield, mp 152–153 oC; 1H-NMR (δ): 2.39 (3H, s, Me), 2.43 (3H, s, Me), 3.12 (1H, dd, J 
= 4.8, 17.7 Hz, 4-Htrans), 3.73 (1H, dd, J = 11.8, 17.7 Hz, 4-Hcis), 5.53 (1H, dd, J = 4.8, 11.8 Hz, 
5-H), 7.09–7.63 (m, 8x arom. H); 13C-NMR (δ): 21.4, 21.8, 42.2, 59.3, 123.8, 125.7, 126.5, 
127.7, 128.4, 129.4, 130.1, 134.7, 140.7, 143.9, 153.7, 168.7;  Anal. Calcd. for C18H17ClN2O: 
C, 69.12; H, 5.48; N, 8.95. Found: C, 69.04; H, 5.53; N, 8.89%. 
1-Acetyl-5-(4-chlorophenyl)-3-(4-methylphenyl)-2-pyrazoline (22). Isolated as white needles 
in 68% yield, mp 127–128 oC; 1H- NMR (δ): 2.38 (3H, s, Me), 2.42 (3H, s, Me), 3.10 (1H, dd, J 
= 4.8, 17.8 Hz, 4-Htrans), 3.74 (1H, dd, J = 11.8, 17.8 Hz, 4-Hcis), 5.54 (1H, dd, J = 4.8, 11.8 Hz, 
5-H), 7.13–7.62 (m, 8x arom. H); 13C- NMR (δ): 21.4, 21.8, 42.2, 59.2, 126.5, 127.0, 128.4, 
Issue in Honor of Prof. J. Elguero and P. Molina ARKIVOC 2005 (ix) 344-352 
ISSN 1424-6376 Page 348 ©ARKAT USA, Inc 
128.9, 129.4, 133.3, 140.4, 140.7, 153.7, 168.7; Anal. Calcd. for C18H17ClN2O: C, 69.12; H, 
5.48; N, 8.95. Found: 69.26; H, 5.42; N, 8.86%.  
1-Acetyl-5-(2,4-dichlorophenyl)-3-(4-methylphenyl)-2-pyrazoline (23). Prepared as white 
plates in 69% yield, mp 187–188 oC; 1H- NMR (δ): 2.38 (3H, s, Me), 2.46 (3H, s, Me), 2.98 (1H, 
dd, J = 5.0, 17.8 Hz, 4-Htrans), 3.80 (1H, dd, J = 11.9, 17.8 Hz, 4-Hcis), 5.82 (1H, dd, J = 5.0, 11.9 
Hz, 5-H), 6.98–7.62 (m, 7x arom. H); 13C- NMR (δ): 21.4, 21.8, 41.3, 57.2, 126.5, 126.9, 127.5, 
128.3, 129.4, 129.7, 132.4, 133.8, 137.3, 140.9, 154.2, 168.8; Anal. Calcd. for C18H16Cl2N2O: C, 
62.26; H, 4.64; N, 8.06. Found: C, 62.39; H, 4.69; N, 8.13%. 
1-Acetyl-5-(2,6-dichlorophenyl)-3-(4-methylphenyl)-2-pyrazoline (24). Prepared as pale 
yellow needles in 68% yield, mp 198–199 oC; 1H- NMR (δ): 2.37 (3H, s, Me), 2.41 (3H, s, Me), 
3.28 (1H, dd J = 7.6, 17.8 Hz, 4-Htrans), 3.67 (1H, dd, J = 13.0, 17.8 Hz, 4-Hcis), 6.21 (1H, dd, J = 
7.6, 13.0 Hz, 5-H), 7.08–7.66 (m, 7x arom. H); 13C- NMR (δ): 21.4, 21.6, 39.1, 56.6, 126.4, 
128.4, 128.6, 128.8, 129.4, 129.8, 133.6, 135.1, 135.8, 140.5, 153.5, 168.8; Anal. Calcd. for 
C18H16Cl2N2O: C, 62.26; H, 4.64; N, 8.06. Found: C, 62.17; H, 4.59; N, 7.97%. 
1-Acetyl-5-(2,4-dichlorophenyl)-3-(4-methoxyphenyl)-2-pyrazoline (25). Obtained as white 
plates in 75% yield, mp 170–171 oC; 1H-NMR (δ): 2.47 (3H, s, Me), 2.99 (1H, dd, J = 4.9, 17.7 
Hz, 4-Htrans), 3.81 (1H, dd, J = 11.8, 17.7 Hz, 4-Hcis), 3.86 (3H, s, MeO), 5.84 (1H, dd, J = 4.9, 
11.8 Hz, 5-H), 6.90–7.70 (m, 7x arom. H); 13C-NMR (δ): 21.8, 41.3, 55.3, 57.1, 123.6, 126.9, 
127.5, 128.1, 129.7, 132.4, 133.7, 137.3, 153.8, 161.4, 168.6; Anal. Calcd. for C18H16Cl2N2O2: 
C, 59.52; H, 4.44; N, 7.71. Found: C, 59.64; H, 4.39; N, 7.78%. 
1-Acetyl-5-(2,6-dichlorophenyl)-3-(4-methoxyphenyl)-2-pyrazoline (26). Prepared as pale 
yellow plates in 69% yield, mp 176–177 oC; 1H- NMR (δ): 2.35 (3H, s, Me), 3.25 (1H, dd, J = 
8.4, 17.7 Hz, 4-Htrans), 3.64 (1H, dd, J = 12.8, 17.7 Hz, 4-Hcis), 3.83 (3H, s, MeO), 6.19 (1H, dd, J 
= 8.4, 12.8 Hz, 5-H), 6.95–7.70 (m, 7x arom. H); 13C- NMR (δ): 21.5, 39.1, 55.3, 56.5, 123.9, 
128.0, 128.4, 128.8, 129.8, 133.6, 135.1, 135.8, 153.2, 161.2, 168.7; Anal. Calcd. for 
C18H16Cl2N2O2: C, 59.52; H, 4.44; N, 7.71. Found: C, 59.41; H, 4.49; N, 7.80%. 
1-Acetyl-3-(4-chlorophenyl)-5-(2,4-dichlorophenyl)-2-pyrazoline (27). Isolated as white 
plates in 76% yield, mp 131–132 oC; 1H- NMR (δ): 2.41 (3H, s, Me), 3.10 (1H, dd, J = 5.1, 17.9 
Hz, 4-Htrans), 4.74 (1H, dd, J = 12.0, 17.9 Hz, 4-Hcis), 5.52 (1H, dd, J = 5.1, 12.0 Hz, 5-H), 7.05–
7.67 (m, 7x arom. H); 13C- NMR (δ): 21.9, 42.1, 59.3, 125.2, 127.8, 127.9, 129.2, 129.6, 131.0, 
131.9, 133.1, 136.7, 152.6, 169.0; Anal. Calcd. for C17H13Cl3N2O: C, 55.53; H, 3.56; N, 7.62. 
Found: C, 55.62; H, 3.52; N, 7.72%. 
1-Acetyl-3-(4-chlorophenyl)-5-(2,6-dichlorophenyl)-2-pyrazoline (28). Obtained as pale 
yellow plates in 80% yield, mp 188–189 oC; 1H-NMR (δ): 2.36 (3H, s, Me), 3.26 (1H, dd, J = 
8.4, 17.7 Hz, 4-Htrans), 3.67 (1H, dd, J = 13.0, 17.7 Hz, 4-Hcis), 6.23 (1H, dd, J = 8.4, 13.0 Hz, 5-
H), 7.10–7.70 (m, 7x arom. H); 13C-NMR (δ): 21.5, 38.9, 56.7, 127.7, 128.4, 128.9, 129.8, 133.5, 
134.8, 135.8, 136.1, 152.3, 168.8; Anal. Calcd. for C17H13Cl3N2O: C, 55.53; H, 3.56; N, 7.62. 
Found: C, 55.46; H, 3.61; N, 7.71%. 
5-(2-Chlorophenyl)-1,3-diphenyl-2-pyrazoline (29). Isolated as pale yellow needles in 90% 
yield, mp 141–142 oC; 1H- NMR (δ): 3.06 (1H, dd, J = 4.9, 17.6 Hz, 4-Htrans), 3.96 (1H, dd, J = 
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11.4, 17.6 Hz, 4-Hcis), 5.64 (1H, dd, J = 4.9, 11.4 Hz, 5-H), 6.76–7.74 (m, 14x arom. H); 13C-
NMR (δ): 41.9, 61.2, 113.1, 119.2, 125.7, 127.3, 127.6, 128.5, 128.6, 128.7, 129.0. 129.8, 131.7, 
132.6, 139.2, 144.4, 147.0; Anal. Calcd. for C21H17ClN2: C, 75.78; H, 5.15; N, 8.41. Found: C, 
75.91; H, 5.19; N, 8.34%. 
5-(4-Chlorophenyl)-1,3-diphenyl-2-pyrazoline (30). Prepared as pale yellow needles in 93% 
yield, mp 133–134 oC; 1H- NMR (δ): 3.04 (1H, dd, J = 7.4, 17.6 Hz, 4-Htrans), 3.77 (1H, dd, J = 
11.6, 17.6 Hz, 4-Hcis), 5.67 (1H, dd, J = 7.4, 11.6 Hz, 5-H), 6.71–7.64 (m, 14x arom. H); 13C- 
NMR (δ): 43.4, 63.8, 113.4, 119.4, 125.7, 127.3, 128.5, 128.7, 128.9, 129.3, 129.9, 132.5, 133.3, 
141.1, 144.6, 146.7; Anal. Calcd. for C21H17ClN2: C, 75.78; H, 5.15; N, 8.41. Found: C, 75.69; 
H; 5.10; N, 8.49%. 
5-(2,4-Dichlorophenyl)-1,3-diphenyl-2-pyrazoline (31). Obtained as yellow plates in 76% 
yield, mp 119–120 oC; 1H- NMR (δ): 3.02 (1H, dd, J = 6.7, 17.3 Hz, 4-Htrans), 3.97 (1H, dd, J = 
12.3, 17.3 Hz, 4-Hcis), 5.59 (1H, dd, J = 6.7, 12.3 Hz, 5-H), 6.69–7.71 (m, 13x arom. H); 13C- 
NMR (δ): 41.8, 60.9, 113.2, 119.5, 124.1, 125.8, 127.3, 127.9, 128.4, 128.6, 128.8, 129.1, 129.7, 
132.4, 133.9, 137.9, 144.2, 147.1; Anal. Calcd. for C21H16Cl2N2: C, 68.67; H, 4.39; N, 7.62. 
Found: C, 68.78; H, 4.34; N, 7.68%. 
5-(2,6-Dichlorophenyl)-1,3-diphenyl-2-pyrazoline (32). Prepared as yellow needles in 65% 
yield, mp 191–192 oC; 1H- NMR (δ): 3.30 (1H, dd, J = 9.6, 17.3 Hz, 4-Htrans), 3.76 (1H, dd, J = 
13.6, 17.3 Hz, 4-Hcis), 6.03 (1H, dd, J = 9.6, 13.6 Hz, 5-H), 6.73–7.76 (m, 13x arom. H); 13C- 
NMR (δ): 39.9, 60.0, 113.1, 119.2, 125.7, 128.5, 128.9, 129.2, 130.8, 132.6, 135.0, 135.2, 135.8, 
144.6, 146.4; Anal. Calcd. for C21H16Cl2N2: C, 68.67; H, 4.39; N, 7.62. Found: C, 68.58; H, 
4.45; N, 7.71%. 
5-(3,4-Dichlorophenyl)-1,3-diphenyl-2-pyrazoline (33). Obtained as yellow needles in 79% 
yield, mp 109–110 oC, 1H- NMR (δ): 3.08 (1h, dd, J = 7.2, 17.2 Hz, 4-Htrans), 3.80 (1H, dd, J = 
12.4, 17.2 Hz, 4-Hcis), 5.19 (1H, dd, J = 7.2, 12.4 Hz, 5-H), 6.79–7.72 (m, 13x arom. H); 13C- 
NMR (δ): 43.4, 63.5, 105.5, 119.6, 125.3, 125.4, 125.8, 127.9, 128.3, 128.6, 128.9, 129.0, 129.2, 
130.3, 131.2, 132.3, 133.2, 142.9, 144.5, 146.8; Anal. Calcd. for C21H16Cl2N2: C, 68.67; H, 4.39; 
N, 7.62. Found: C, 68.61; H, 4.43; N, 7.54%. 
5-(3-Chlorophenyl)-3-(4-methylphenyl)-1-phenyl-2-pyrazoline (34). Isolated as pale yellow 
plates in 72% yield, mp 127–128 oC; 1H- NMR (δ): 2.42 (3H, s, Me), 3.04 (1H, dd, J = 5.1, 17.7 
Hz, 4-Htrans), 3.87 (1H, dd, J = 11.2, 17.7 Hz, 4-Hcis), 5.23 (1H, dd, J = 5.1, 11.2 Hz, 5-H), 6.84–
7.67 (m, 13x arom. H); 13C- NMR (δ): 21.3, 43.6, 63.9, 113.3, 119.2, 124.0, 125.4, 125.7, 126.1, 
127.8, 128.9, 129.2, 129.7, 130.4, 134.9, 138.8, 144.9, 146.9; Anal. Calcd. for C22H19ClN2: C, 
76.18; H, 5.52; N, 8.07. Found: C, 76.29; H, 5.47; N, 8.16%. 
5-(4-Chlorophenyl)-3-(4-methylphenyl)-1-phenyl-2-pyrazoline (35). Prepared as pale yellow 
plates in 75% yield, mp 155–156 oC; 1H- NMR δ 2.42 (3H, s, Me), 3.13 (1H, dd, J = 5.3, 17.8 
Hz, 4-Htrans), 3.87 (1H, dd, J = 11.5, 17.8 Hz, 4-Hcis), 5.28 (1H, dd, J = 5.3, 11.5 Hz, 5-H), 6.80–
7.67 (m, 13x arom. H); 13C- NMR (δ): 21.3, 43.6, 63.8, 105.1, 113.4, 119.2, 124.8, 125.5, 125.7, 
125.9, 127.3, 128.8, 128.9, 129.4, 130.5, 133.3, 134.5, 138.8, 144.8, 146.9; Anal. Calcd. for 
C22H19ClN2: C, 76.18; H, 5.52; N, 8.07. Found: 76.08; H, 5.59; N, 7.93%. 
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5-(2,4-Dichlorophenyl)-3-(4-methylphenyl)-1-phenyl-2-pyrazoline (36). Obtained as yellow 
needles in 76% yield, mp 130–131 oC; 1H-NMR (δ): 2.39 (3H, s, Me), 3.03 (1H, dd, J = 4.9, 17.8 
Hz, 4-Htrans), 3.98 (1H, dd, J = 9.8, 17.8 Hz, 4-Hcis), 5.60 (1H, dd, J = 4.9, 9.8 Hz, 5-H), 6.70–
7.67 (m, 12x arom. H); 13C-NMR (δ): 21.4, 41.9, 60.8, 113.1, 119.3, 125.8, 127.9, 128.5, 129.1, 
129.3, 129.7, 132.4, 133.8, 138.0, 139.0, 144.4, 147.3; Anal. Calcd. for C22H18Cl2N2: C, 69.30; 
H, 4.76; N, 7.34. Found: C, 69.38; H, 4.81; N, 7.25%. 
5-(2,6-Dichlorophenyl)-3-(4-methylphenyl)-1-phenyl-2-pyrazoline (37). Isolated as pale 
yellow needles in 76% yield, mp 185–186 oC; 1H-NMR (δ): 2.44 (3H, s, Me), 3.38 (1H, dd, J = 
9.4, 17.5 Hz, 4-Htrans), 3.82 (1H, dd, J = 13.4, 17.5 Hz, 4-Hcis), 6.09 (1H, dd, J = 9.4. 13.4 Hz, 5-
H), 6.80–7.69 (m, 12x arom. H); 13C-NMR (δ): 21.4, 40.0, 59.9, 113.0, 119.0, 125.7, 128.4, 
128.9, 129.2, 129.8, 130.8, 135.0, 135.2, 135.9, 138.6, 144.8, 146.5; Anal. Calcd. for 
C22H18Cl2N2: C, 69.30; H, 4.76; N, 7.34. Found: C, 69.21; H, 4.71; N, 3.44%.  
5-(2,4-Dichlorophenyl-3-(4-methoxyphenyl)-1-phenyl-2-pyrazoline (38). Prepared as yellow 
plates in 79% yield, mp 124–125 oC; 1H- NMR (δ): 3.02 (1H, dd, J = 6.1, 17.9 Hz, 4-Htrans), 3.85 
(3H, s, MeO), 3.97 (1H, dd, J = 12.8, 17.9 Hz, 4-Hcis), 5.59 (1H, dd, J = 6.1, 12.8 Hz, 5-H), 6.80–
7.70 (m, 12x arom. H); 13C- NMR (δ): 40.9, 54.3, 59.8, 111.9, 112.9, 118.1, 124.1, 126.2, 126.8, 
127.4, 128.0, 128.6, 131.4, 132.7, 137.0, 143.5, 146.1, 159.3; Anal. Calcd. for C22H18Cl2N2O: C, 
66.51; H, 4.57; N, 7.05. Found: C, 66.61; H, 4.62; N, 7.14%. 
5-(2,6-Dichlorophenyl)-3-(4-methoxyphenyl)-1-phenyl-2-pyrazoline (39). Prepared as pale 
yellow needles in 75% yield, mp 178–179 oC; 1H- NMR (δ): 3.34 (1H, dd, J = 9.1, 17.6 Hz, 4-
Htrans), 3.80 (1H, dd, J = 13.2, 17.6 Hz, 4-Hcis), 3.88 (3H, s, MeO), 6.04 (1H, dd, J = 9.1, 13.2 Hz, 
5-H), 6.77–7.74 (m, 12x arom. H); 13C- NMR (δ): 40.2, 55.4, 60.1, 113.0, 114.1, 118.9, 125.4, 
127.2, 128.5, 128.9, 129.2, 130.8, 135.1, 136.0, 145.0, 146.5, 160.2; Anal. Calcd. for 
C22H18Cl2N2O: C, 66.51; H, 4.57; N, 7.05. Found: C, 66.43; H, 4.51; N, 7.14%. 
5-(3,4-Dichlorophenyl)-3-(4-fluorophenyl)-1-phenyl-2-pyrazoline (40). Obtained as pale 
yellow plates in 76% yield, mp 131–132 oC; 1H-NMR (δ): 3.11 (1H, dd, J = 5.3, 17.6 Hz, 4-
Htrans), 3.88 (1H, dd, J = 11.4, 17.6 Hz, 4-Hcis), 5.77 (1H, dd, J = 5.3, 11.4 Hz, 5-H), 6.82–7.77 
(m, 12x arom. H); 13C-NMR (δ): 43.5, 63.6, 105.3, 113.4, 115.5, 115.9, 119.7, 125.2, 127.5, 
127.6, 127.9, 128.1, 129.0, 130.3, 131.2, 142.8, 144.5; Anal. Calcd. for C21H15FCl2N2: C, 65.47; 
H, 3.92; N, 7.27. Found: C, 65.58; H, 3.95; N, 7.38%. 
3-(4-Chlorophenyl)-5-(2,4-dichlorophenyl)-1-phenyl-2-pyrazoline (41). Isolated as yellow 
needles in 81% yield, mp 156–157 oC; 1H- NMR (δ): 3.03 (1H, dd, J = 5.9, 17.4 Hz, 4-Htrans), 
3.98 (1H, dd, J = 11.9, 17.4 Hz, 4-Hcis), 5.66 (1H, dd, J = 5.9, 11.9 Hz, 5-H), 6.82–7.70 (m, 12x 
arom. H); 13C- NMR (δ): 41.6, 61.0, 113.2, 119.7, 124.1, 126.9, 127.9, 128.3, 128.8, 129.1, 
129.8, 130.9, 132.4, 134.0, 134.6, 137.7, 144.0, 145.9; Anal. Calcd. for C21H15Cl3N2: C, 62.78; 
H, 3.76; N, 6.97. Found: C, 62.88; H, 3.70; N, 6.88%. 
3-(4-Chlorophenyl)-5-(2,6-dichlorophenyl)-1-phenyl-2-pyrazoline (42). Prepared as pale 
yellow needles in 71% yield, mp 193–194 oC; 1H- NMR (δ): 3.33 (1H, dd, J = 9.3, 17.8 Hz, 4-
Htrans), 3.80 (1H, dd, J = 12.7, 17.8 Hz, 4-Hcis), 6.12 (1H, dd, J = 9.3, 12.7 Hz, 5-H), 6.79–7.71 
(m, 12x arom. H); 13C- NMR (δ): 39.7, 60.1, 113.1, 119.4, 126.8, 128.5, 128.7, 128.9, 129.3, 
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130.8, 131.1, 134.2, 135.0, 135.6, 144.3, 145.2; Anal. Calcd. for C21H15Cl3N2: C, 62.78; H, 3.76, 
N, 6.97. Found: C, 62.64; H, 3.80; N, 7.04%. 
3-(4-Chlorophenyl)-5-(3,4-dichlorophenyl)-1-phenyl-2-pyrazoline (43). Isolated as yellow 
needles in 77% yield, mp 136–137 oC; 1H- NMR (δ): 3.09 (1H, dd, J = 5.9, 17.7 Hz, 4-Htrans), 
3.86 (1H, dd, J = 11.9, 17.7 Hz, 4-Hcis), 5.27 (1H, dd, J = 5.9, 11.9 Hz, 5-H), 6.82–7.70 (m, 12x 
arom. H); 13C- NMR (δ): 43.3, 63.7, 105.4, 113.2, 125.3, 126.9, 127.8, 128.9, 129.8, 130.5, 
131.8, 132.9, 133.6, 134.6, 139.5, 142.7, 144.3, 145.6, 151.1; Anal. Calcd. for C21H15Cl3N2: C, 
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